Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Editas Medicine (NASDAQ:EDIT) through any online brokerage.
Other companies in Editas Medicine’s space includes: Molecular Partners AG (NASDAQ:MOLN), Kalaris Therapeutics Inc (NASDAQ:KLRS), Galectin Therapeutics Inc (NASDAQ:GALT), Humacyte Inc (NASDAQ:HUMA) and Voyager Therapeutics Inc (NASDAQ:VYGR).
Editas Medicine has a consensus price target of $8.71.
The stock price for Editas Medicine (NASDAQ: EDIT) is $2.05 last updated March 4, 2026 at 8:11 AM EST.
There are no upcoming dividends for Editas Medicine.
Editas Medicine does not have any upcoming earnings scheduled.
There is no upcoming split for Editas Medicine.
Editas Medicine is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.